Taiwanese Animators Totally Nail Pharma PR Disaster Martin Shkreli

Meanwhile, the Embattled Exec Folds and Decides to Reduce the Price of Daraprim

By Published on .

Reprints Reprints

Turing Pharmaceuticals CEO Martin Shkreli -- the man who aquired the rights to the life-saving drug Daraprim and then arbitrarily raised the price by 5,000% -- has been the subject of withering mainstream-media coverage and nonstop attacks on social media the past several days. Now he's also the star of a cartoon (posted on the Taiwanese Animators YouTube channel) that calls him "a litle weasel" and declares Turing to be "by far the greediest and douchiest" drug company. But there's one thing missing from the very entertaining short video -- the fact that last night Shkreli folded, telling NBC News that he intends to cut the price of Daraprim in response to all the criticism. He'd previously increased it from $13.50 to $750 per pill; according to NBC News, "Martin Shkreli did not say what the new price would be, but expected a determination to be made over the next few weeks." Stay tuned.

Simon Dumenco, aka Media Guy, is an Ad Age editor-at-large. You can follow him on Twitter @simondumenco.

Most Popular